Herbert Opitz
Impact in
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 5%
- Iron Metabolism and Disorders
- Acute Myeloid Leukemia Research
- Blood groups and transfusion
- Erythropoietin and Anemia Treatment
Papers in
- Genetics 6
- Hemoglobinopathies and Related Disorders 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Iron Metabolism and Disorders 5
- Co-authors
- Maria Domenica Cappellini (3 shared papers)J. Ford (3 shared papers)Antonella Lavagetto (1 shared paper)Raffaella Origa (1 shared paper)Gian Luca Forni (1 shared paper)Renzo Galanello (1 shared paper)Guido Di Donato (1 shared paper)Romain Séchaud (1 shared paper)
- Journals
- Blood (5 papers)PubMed (1 paper)
- Partner nations
- SwitzerlandItalyGreece
In The Last Decade
Herbert Opitz
6 papers receiving 263 citations
Peers
Comparison fields: 5 of 51
- Genetics 243
- Hematology 239
- Pediatrics, Perinatology and Child Health 66
- Nutrition and Dietetics 30
- Family Practice 2
Countries citing papers authored by Herbert Opitz
This map shows the geographic impact of Herbert Opitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Opitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Opitz more than expected).
Fields of papers citing papers by Herbert Opitz
This network shows the impact of papers produced by Herbert Opitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Opitz. The network helps show where Herbert Opitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Herbert Opitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. | 2006 | 226 |
| 2 | 2005 | 16 | |
| 3 | 2005 | 12 | |
| 4 | 2005 | 9 | |
| 5 | 2005 | 8 | |
| 6 | 2004 | 7 |
About Herbert Opitz
Herbert Opitz is a scholar working on Genetics, Hematology, Pediatrics, Perinatology and Child Health, Physiology and Economics and Econometrics, having authored 6 papers that have together received 278 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (6 papers), Iron Metabolism and Disorders (5 papers), Pharmacological Effects and Toxicity Studies (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Erythrocyte Function and Pathophysiology (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Genetics (243 citations), Hematology (239 citations), Pediatrics, Perinatology and Child Health (66 citations), Nutrition and Dietetics (30 citations) and Family Practice (2 citations). Herbert Opitz has collaborated with scholars based in Switzerland, Italy and Greece. Frequent co-authors include Maria Domenica Cappellini, J. Ford, Antonella Lavagetto, Raffaella Origa, Gian Luca Forni, Renzo Galanello, Guido Di Donato, Romain Séchaud, Antonio Piga and Nicola Hewson. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.